title: Cardiovascular and metabolic risks associated with PCOS.
abstract: Polycystic ovary syndrome, the most common endocrine disorder of reproductive age women, is often associated with insulin resistance and associated disorders. The frequency of type 2 diabetes, hyperlipidemia, cardiac risk markers, structural vascular disease, and clinical disease events are increased in this population of women. PCOS, however, represents a broad spectrum of clinical presentations, as defined by different criteria proposed in Europe and the United States. The role of insulin resistance and hence the risk of cardiometabolic disorders may in part be determined by the definition of PCOS used. Epidemiologic studies and clinical trials support the need to identify women with PCOS to determine their risk of cardiometabolic disorders to prevent and/or treat their serious consequences.
authors.affiliation: The Mount Sinai School of Medicine, New York, NY, USA. rhcobin@gmail.com
authors.forename: Rhoda H
authors.initials: RH
authors.lastname: Cobin
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D005260:Female; D006801:Humans; D007333:Insulin Resistance; D008055:Lipids / Q000097:blood; D024821:Metabolic Syndrome / Q000150:complications; D011085:Polycystic Ovary Syndrome / Q000150:complications* / Q000175:diagnosis
chemical_list: D008055:Lipids